Insider Cluster (4 insiders) ·Filed Feb 23, 2026

VIR

Vir Biotechnology, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed7mo ago
Insider cluster: 4 insiders, $0.2M total
Actionable Insight • Neutral

This cluster reflects routine post-vesting selling behavior rather than negative sentiment. Traders should monitor for continued selling beyond this cluster or changes in guidance as potential red flags. The lack of buying, however, limits any bullish readthrough.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
VIR ▲ +18.04% at T+60d
NEUTRAL call ✓ call won +18.04% · α vs SPY +9.78% · entry $7.43 → $8.77
Entry anchored
Feb 20, 03:59 PM ET
via exchange tick
T+1d
+27.73%
call +27.73% · α +26.99%
$9.49
settled 7mo ago
T+5d
+25.71%
call +25.71% · α +25.09%
$9.34
settled 7mo ago
T+20d
+18.98%
call +18.98% · α +22.92%
$8.84
settled 7mo ago
T+60d
+18.04%
call +18.04% · α +9.78%
$8.77
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Multiple top executives at Vir Biotechnology, including the CEO, CFO, and Chief Medical Officer, sold shares in a coordinated cluster over two days, totaling over $206,000 in sales. The same insiders also received stock awards totaling 450,000 shares, indicating a routine grant or vesting event. The sales appear to be part of a planned transaction, likely related to tax or diversification strategies following the award vesting.

Key Financial Metrics

Direction
selling
Total Value
$205.2K
Insiders
4

Key Facts

  • CEO Marianne De Backer sold $141,894 worth of shares, the largest individual sale.
  • All four C-suite insiders sold shares at $7.4528 per share on 2026-02-23, immediately after receiving large stock awards on 2026-02-22.
  • Total sales value: $205,159.35 across 27,662 shares.
  • Insiders collectively received 450,000 shares via awards at $0 cost, consistent with vesting of prior grants.
  • No open-market purchases were made; all activity was sales or awards.

Financial Impact

$205,159 in insider sales; no direct financial impact to company balance sheet.

insider ownershipshare countpotential dilution

Risk Factors

  • Perception of insider pessimism if media or investors misinterpret sales as sentiment-driven.
  • Potential for increased share supply in the market from ongoing executive selling.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (8 trades, 7d window)cluster-VIR-1771978367193
18 reports for VIR
Performance horizon
40% Hit rate 2 of 5 directional calls best @ T+60▲ +10.12%Feb 24, 2026
Filters
Rows
Reports for VIR — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Court Ruling
NEUTRAL ★ 1/10
$9.24 $9.78▲ +5.84%▲ +7.21%$11.17 (+20.89%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$8.89 $9.39▲ +5.62%▲ +5.67%$11.17 (+25.65%)
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$8.69 $8.90▲ +2.42%▲ +2.04%$11.17 (+28.54%)
Jun 29, 2026
13w ago
144
NEUTRAL ★ 2/10
$10.38 $10.02▼ −3.47%▼ −4.86%$11.17 (+7.61%)
Jun 10, 2026
16w ago
3
NEUTRAL ★ 1/10
$8.52 $9.30▲ +9.15%▲ +8.72%$11.17 (+31.10%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$8.52 $9.30▲ +9.15%▲ +8.72%$11.17 (+31.10%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.77 $8.25▼ −5.93%▼ −2.11%$11.17 (+27.37%)
May 28, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$9.55 $8.77▼ −8.17%▼ −8.12%$11.17 (+16.96%)
Apr 16, 2026
24w ago
DEFA14A
NEUTRAL ★ 3/10
$10.33 $10.35▲ +0.19%▼ −0.79%$11.17 (+8.13%)
Apr 10, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$9.31 $11.09▲ +19.12%▲ +15.82%$11.17 (+19.98%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Feb 25, 2026